Aspen Pays $263M For GSK's Zantac, Other OTC Drugs
GlaxoSmithKline PLC will sell five international over-the-counter drug brands including antacid Zantac for £164 million ($263 million) to South Africa's Aspen Pharmacare Holdings Ltd., GSK said Friday, the third such sale...To view the full article, register now.
Already a subscriber? Click here to view full article